Trade Filings
Managers Aandelen Ingediende stukken Superinvesteerders
Signalen Institutionele aankopen Institutionele verkopen Insider-activiteit 13D & 13G Watch Sectorrotatie
Tools Aandelenscreener Manager Screener Beheerders vergelijken Consensusmandjes Alle onderzoekstools Data-API
Leren & AI Leren Vraag de data AI-agents
Nieuws ★ Opgeslagen
Over Over ons Methodologie Contact Disclaimer
Reader
DATAPAKKETTEN

Downloads van historische gegevens — beschikbaar met accounts.

API GATEWAY

Gratis alleen-lezen JSON-toegang tot de gecachede gegevens van de site.

Donkere modus

🧭 Begeleide weergave
Nieuw met markten — koersen, yields, YTD, marktkapitalisatie? We leggen elk begrip uit terwijl u bladert, in begrijpelijke taal. Dezelfde data, met ingebouwde uitleg.

⚡ Expertvisie
U kent de markt al. Alleen de data — schoon, snel en compact, zonder extra uitleg. Dit is de standaardweergave.

Interfacetaal
Effectdossier · gearchiveerd kwartaal

ROIV

Roivant Sciences Ltd. · Healthcare · Biotechnology

36.47 +0.3% marktkapitalisatie $26.35B koers vertraagd (FMP) · per Aug 25 22:08 UTC — los van onderstaande aangiftegegevens

Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024
131Gevolgde houders
+11Δ houders
408.23MGehouden aandelen
$14.45BGerapporteerde waarde
+15Nieuwe posities
−3Uitstappen
Rising Overtuigingsscore 63/100 5 kwartalen van stijgende gevolgde aandelen ●●●●● Hoe deze worden berekend → Dit toelichten aan de Research Desk →

Momentum-inputs (vergelijkbare managers): breedte van houders +9.2% · aandelenstroom +5.9% · netto nieuwe posities +9.2%formule
Brede accumulatie — stijgende aandelen bij meer houders

Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q2 2026

Eigendom in de tijd
KwartaalHoudersΔAandelenGerapporteerde waardeNieuwUitstappen
Q2 2026 131 +11 408.23M $14.45B +15 −3
Q1 2026 122 +5 384.63M $10.65B +13 −9
Q4 2025 117 +1 374.22M $8.12B +3 −1
Q3 2025 19 +1 262.46M $3.97B +1 −1
Q2 2025 16 +1 211.12M $2.38B +1
Q1 2025 12 +1 89.39M $901.93M +2 −1
Q4 2024 11 -2 96.86M $1.15B −2
Q3 2024 12 -1 85.45M $986.08M +1 −2
Q2 2024 13 92.40M $976.70M
Aantal houders
Wie het bezit · Q2 2026
#ManagerAandelenΔ aandelenWaardeHun gewichtGehouden
1 Fidelity (FMR) 81.02M +3.9% $2.87B 0.1% ▲ Add 5 SEC ↗
2 Fidelity (FMR) 81.02M +3.9% $2.87B 0.1% ▲ Add 5 SEC ↗
3 Fidelity (FMR) 81.02M +3.9% $2.87B 0.1% ▲ Add 5 SEC ↗
4 Fidelity (FMR) 81.02M +3.9% $2.87B 0.1% ▲ Add 5 SEC ↗
5 Fidelity (FMR) 81.02M +3.9% $2.87B 0.1% ▲ Add 5 SEC ↗
6 Fidelity (FMR) 81.02M +3.9% $2.87B 0.1% ▲ Add 5 SEC ↗
7 Morgan Stanley 42.59M -17.8% $1.51B 0.1% ▼ Trim 4 SEC ↗
8 Morgan Stanley 42.59M -17.8% $1.51B 0.1% ▼ Trim 4 SEC ↗
9 Morgan Stanley 42.59M -17.8% $1.51B 0.1% ▼ Trim 4 SEC ↗
10 Morgan Stanley 42.59M -17.8% $1.51B 0.1% ▼ Trim 4 SEC ↗
11 Morgan Stanley 42.59M -17.8% $1.51B 0.1% ▼ Trim 4 SEC ↗
12 Morgan Stanley 42.59M -17.8% $1.51B 0.1% ▼ Trim 4 SEC ↗
13 Morgan Stanley 42.59M -17.8% $1.51B 0.1% ▼ Trim 4 SEC ↗
14 Morgan Stanley 42.59M -17.8% $1.51B 0.1% ▼ Trim 4 SEC ↗
15 Morgan Stanley 42.59M -17.8% $1.51B 0.1% ▼ Trim 4 SEC ↗
16 Morgan Stanley 42.59M -17.8% $1.51B 0.1% ▼ Trim 4 SEC ↗
17 Morgan Stanley 42.59M -17.8% $1.51B 0.1% ▼ Trim 4 SEC ↗
18 Morgan Stanley 42.59M -17.8% $1.51B 0.1% ▼ Trim 4 SEC ↗
19 Morgan Stanley 42.59M -17.8% $1.51B 0.1% ▼ Trim 4 SEC ↗
20 Morgan Stanley 42.59M -17.8% $1.51B 0.1% ▼ Trim 4 SEC ↗
21 Goldman Sachs Group 18.56M +67.0% $656.71M 0.1% ▲ Add 4 SEC ↗
22 Goldman Sachs Group 18.56M +67.0% $656.71M 0.1% ▲ Add 4 SEC ↗
23 Goldman Sachs Group 18.56M +67.0% $656.71M 0.1% ▲ Add 4 SEC ↗
24 Goldman Sachs Group 18.56M +67.0% $656.71M 0.1% ▲ Add 4 SEC ↗
25 Goldman Sachs Group 18.56M +67.0% $656.71M 0.1% ▲ Add 4 SEC ↗
26 State Street Global Advisors (passief) 17.80M +9.9% $629.80M 0.0% ▲ Add 7 SEC ↗
27 Geode Capital Management (passief) 11.67M +14.7% $425.54M 0.0% ▲ Add 9 SEC ↗
28 Geode Capital Management (passief) 11.67M +14.7% $425.54M 0.0% ▲ Add 9 SEC ↗
29 Adage Capital Partners 10.35M -19.1% $366.26M 0.5% ▼ Trim 9 SEC ↗
30 Invesco Ltd. 7.53M +17.0% $266.53M 0.0% ▲ Add 3 SEC ↗
31 Invesco Ltd. 7.53M +17.0% $266.53M 0.0% ▲ Add 3 SEC ↗
32 Invesco Ltd. 7.53M +17.0% $266.53M 0.0% ▲ Add 3 SEC ↗
33 Invesco Ltd. 7.53M +17.0% $266.53M 0.0% ▲ Add 3 SEC ↗
34 Invesco Ltd. 7.53M +17.0% $266.53M 0.0% ▲ Add 3 SEC ↗
35 Invesco Ltd. 7.53M +17.0% $266.53M 0.0% ▲ Add 3 SEC ↗
36 AQR Capital Management 6.63M +11.6% $234.03M 0.1% ▲ Add 4 SEC ↗
37 AQR Capital Management 6.63M +11.6% $234.03M 0.1% ▲ Add 4 SEC ↗
38 AQR Capital Management 6.63M +11.6% $234.03M 0.1% ▲ Add 4 SEC ↗
39 AQR Capital Management 6.63M +11.6% $234.03M 0.1% ▲ Add 4 SEC ↗
40 AQR Capital Management 6.63M +11.6% $234.03M 0.1% ▲ Add 4 SEC ↗
41 AQR Capital Management 6.63M +11.6% $234.03M 0.1% ▲ Add 4 SEC ↗
42 AQR Capital Management 6.63M +11.6% $234.03M 0.1% ▲ Add 4 SEC ↗
43 AQR Capital Management 6.63M +11.6% $234.03M 0.1% ▲ Add 4 SEC ↗
44 Viking Global Investors 6.27M -5.7% $221.95M 0.6% ▼ Trim 9 SEC ↗
45 Dimensional Fund Advisors Lp 5.23M -30.0% $185.06M 0.0% ▼ Trim 3 SEC ↗
46 Dimensional Fund Advisors Lp 5.23M -30.0% $185.06M 0.0% ▼ Trim 3 SEC ↗
47 Dimensional Fund Advisors Lp 5.23M -30.0% $185.06M 0.0% ▼ Trim 3 SEC ↗
48 Dimensional Fund Advisors Lp 5.23M -30.0% $185.06M 0.0% ▼ Trim 3 SEC ↗
49 Dimensional Fund Advisors Lp 5.23M -30.0% $185.06M 0.0% ▼ Trim 3 SEC ↗
50 T. Rowe Price 4.82M -31.1% $170.47M 0.0% ▼ Trim 9 SEC ↗
51 T. Rowe Price 4.82M -31.1% $170.47M 0.0% ▼ Trim 9 SEC ↗
52 Jennison Associates Llc 4.48M +50.3% $158.62M 0.1% ▲ Add 3 SEC ↗
53 Jennison Associates Llc 4.48M +50.3% $158.62M 0.1% ▲ Add 3 SEC ↗
54 Bank Of America Corp /De/ 4.34M +37.2% $153.64M 0.0% ▲ Add 3 SEC ↗
55 Bank Of America Corp /De/ 4.34M +37.2% $153.64M 0.0% ▲ Add 3 SEC ↗
56 Bank Of America Corp /De/ 4.34M +37.2% $153.64M 0.0% ▲ Add 3 SEC ↗
57 Bank Of America Corp /De/ 4.34M +37.2% $153.64M 0.0% ▲ Add 3 SEC ↗
58 Bank Of America Corp /De/ 4.34M +37.2% $153.64M 0.0% ▲ Add 3 SEC ↗
59 Northern Trust Corp 3.76M +6.9% $133.14M 0.0% ▲ Add 3 SEC ↗
60 Northern Trust Corp 3.76M +6.9% $133.14M 0.0% ▲ Add 3 SEC ↗
61 Northern Trust Corp 3.76M +6.9% $133.14M 0.0% ▲ Add 3 SEC ↗
62 Northern Trust Corp 3.76M +6.9% $133.14M 0.0% ▲ Add 3 SEC ↗
63 Northern Trust Corp 3.76M +6.9% $133.14M 0.0% ▲ Add 3 SEC ↗
64 Northern Trust Corp 3.76M +6.9% $133.14M 0.0% ▲ Add 3 SEC ↗
65 Charles Schwab Investment… 3.72M +7.5% $131.49M 0.0% ▲ Add 3 SEC ↗
66 Charles Schwab Investment… 3.72M +7.5% $131.49M 0.0% ▲ Add 3 SEC ↗
67 Manufacturers Life Insurance… 2.99M +327.4% $105.75M 0.1% ▲ Add 3 SEC ↗
68 D. E. Shaw & Co. 2.97M +113.4% $105.20M 0.1% ▲ Add 5 SEC ↗
69 D. E. Shaw & Co. 2.97M +113.4% $105.20M 0.1% ▲ Add 5 SEC ↗
70 National Bank Of Canada /Fi/ 2.77M -56.0% $98.17M 0.1% ▼ Trim 3 SEC ↗
71 National Bank Of Canada /Fi/ 2.77M -56.0% $98.17M 0.1% ▼ Trim 3 SEC ↗
72 Wellington Management 2.69M +179.0% $95.12M 0.0% ▲ Add 2 SEC ↗
73 Wellington Management 2.69M +179.0% $95.12M 0.0% ▲ Add 2 SEC ↗
74 Wellington Management 2.69M +179.0% $95.12M 0.0% ▲ Add 2 SEC ↗
75 Wellington Management 2.69M +179.0% $95.12M 0.0% ▲ Add 2 SEC ↗
76 Citigroup Inc 2.23M +44.9% $78.75M 0.0% ▲ Add 3 SEC ↗
77 Citigroup Inc 2.23M +44.9% $78.75M 0.0% ▲ Add 3 SEC ↗
78 Citigroup Inc 2.23M +44.9% $78.75M 0.0% ▲ Add 3 SEC ↗
79 Bnp Paribas Financial Markets 2.07M -17.6% $73.37M 0.0% ▼ Trim 3 SEC ↗
80 Marshall Wace 1.42M -36.7% $50.31M 0.0% ▼ Trim 9 SEC ↗
81 Marshall Wace 1.42M -36.7% $50.31M 0.0% ▼ Trim 9 SEC ↗
82 Bank Of Nova Scotia 1.24M -5.5% $43.84M 0.1% ▼ Trim 3 SEC ↗
83 Rhumbline Advisers 1.18M +5.9% $41.72M 0.0% ▲ Add 3 SEC ↗
84 JPMorgan Chase 1.14M -26.0% $40.33M 0.0% ▼ Trim 4 SEC ↗
85 JPMorgan Chase 1.14M -26.0% $40.33M 0.0% ▼ Trim 4 SEC ↗
86 JPMorgan Chase 1.14M -26.0% $40.33M 0.0% ▼ Trim 4 SEC ↗
87 JPMorgan Chase 1.14M -26.0% $40.33M 0.0% ▼ Trim 4 SEC ↗
88 JPMorgan Chase 1.14M -26.0% $40.33M 0.0% ▼ Trim 4 SEC ↗
89 JPMorgan Chase 1.14M -26.0% $40.33M 0.0% ▼ Trim 4 SEC ↗
90 Principal Financial Group Inc 1.02M +1.9% $36.24M 0.0% ▲ Add 3 SEC ↗
91 Principal Financial Group Inc 1.02M +1.9% $36.24M 0.0% ▲ Add 3 SEC ↗
92 Amundi 997.23K -32.7% $35.29M 0.0% ▼ Trim 3 SEC ↗
93 Amundi 997.23K -32.7% $35.29M 0.0% ▼ Trim 3 SEC ↗
94 Arrowstreet Capital 823.41K +501.5% $29.14M 0.0% ▲ Add 3 SEC ↗
95 California Public Employees… 791.96K +14.5% $28.03M 0.0% ▲ Add 2 SEC ↗
96 Legal & General Group Plc 721.55K +28.6% $25.54M 0.0% ▲ Add 3 SEC ↗
97 Legal & General Group Plc 721.55K +28.6% $25.54M 0.0% ▲ Add 3 SEC ↗
98 Legal & General Group Plc 721.55K +28.6% $25.54M 0.0% ▲ Add 3 SEC ↗
99 Ameriprise Financial Inc 701.64K +60.0% $24.83M 0.0% ▲ Add 3 SEC ↗
100 Ameriprise Financial Inc 701.64K +60.0% $24.83M 0.0% ▲ Add 3 SEC ↗

"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.

Nieuwe kopers

Geen nieuwe bijgehouden kopers dit kwartaal.

Verlaten

Geen bijgehouden uitstappen dit kwartaal.

Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 436 houders, 528.48M aandelen, $14.35B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.

Vaak gezamenlijk in bezit

Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.

Insider-transacties

Open-market aankopen (P)

Geen open-market insider-aankopen in ons dekkingsvenster.

Open-market verkopen (S)

Aug 21 Sukhatme Mayukh

Officer, Director · 144.76K aand · $5.28M

Aug 20 Sukhatme Mayukh

Officer, Director · 17.52K aand · $653,459

Aug 19 Sukhatme Mayukh

Officer, Director · 172.90K aand · $6.43M

Toekenningen, uitoefeningen en belastinginhoudingen worden hier nooit meegeteld als aankopen of verkopen. Methodologie

Beneficial ownership
Aug 13 SC 13G/A — MORGAN STANLEY

Originele SEC-indiening bekijken ↗

Herkomst: Eigendom op basis van geparseerde 13F common-stockposities (gevolgde universum, vergelijkbare sets voor wijzigingen); insider-rijen afkomstig van formulieren 3/4/5; belangen uit Schedules 13D/13G; elke indiening verwijst naar het origineel op SEC EDGAR. Rapportageperiode: Q2 2026 · Methodologie · Verkrijg dit via de API